DARZALEX

Facts of DARZALEX

• Medicine Name: DARZALEX
• Medicine Name: daratumumab
• Company Name: Janssen Biotec

What is DARZALEX?

DARZALEX is a human CD38-directed monoclonal antibody indicated for the treatment of patients with multiple myeloma who have received at least three prior lines of therapy including a proteasome inhibitor (PI) and an immunomodulatory agent or who are double-refractory to a PI and an immunomodulatory agent